Asaf Danziger
2017
In 2017, Asaf Danziger earned a total compensation of $4.3M as Chief Executive Officer at NovoCure, a 173% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $643,668 |
|---|---|
| Option Awards | $1,533,150 |
| Salary | $698,439 |
| Stock Awards | $1,144,000 |
| Other | $292,331 |
| Total | $4,311,588 |
Danziger received $1.5M in option awards, accounting for 36% of the total pay in 2017.
Danziger also received $643.7K in non-equity incentive plan, $698.4K in salary, $1.1M in stock awards and $292.3K in other compensation.
Rankings
In 2017, Asaf Danziger's compensation ranked 2,315th out of 14,666 executives tracked by ExecPay. In other words, Danziger earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,315 out of 14,666 | 84th |
Division Manufacturing | 810 out of 5,772 | 86th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 104 out of 859 | 88th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 54 out of 531 | 90th |
Industry Surgical and Medical Instruments and Apparatus | 34 out of 336 | 90th |
Source: SEC filing on April 20, 2018.
Danziger's colleagues
We found four more compensation records of executives who worked with Asaf Danziger at NovoCure in 2017.